Article: Cardiac Science Announces Third Quarter Results.

Company Reports $38.9M Q3 Revenue; Takes AED Field Product Update Charge of $18.5M and Non-cash Deferred Tax Assets Charge of $44.0M

BOTHELL, Wash., Nov. 9 /PRNewswire-FirstCall/ -- Cardiac Science Corporation , a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, today announced revenue of $38.9 million for the third quarter ended September 30, 2009, in line with its previous guidance. The Company also recorded a charge of $18.5 million for an AED field product update and a non-cash charge of $44.0 million to increase its valuation allowance against deferred income tax assets. Including these charges, the Company ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!